High doses of saw palmetto appear safe over 18 months

High doses of saw palmetto appear safe over 18 months
Extracts of saw palmetto berry used at doses of up to 960 mg daily appear to be safe over an 18-month period, according to a study published in the April issue of The Journal of Urology.

(HealthDay)—Extracts of saw palmetto berry used at doses of up to 960 mg daily appear to be safe over an 18-month period, according to a study published in the April issue of The Journal of Urology.

Noting that saw palmetto berry extracts are used as self-treatment for lower urinary tract symptoms associated with , Andrew L. Avins, M.D., M.P.H., from Northern California Kaiser-Permanente Division of Research in Oakland, and colleagues examined the safety of saw palmetto extract among 357 men participating in the for Urological Symptoms trial. During 18 months of follow-up, participants were randomized to receive 320, 640, and 960 mg daily of an ethanolic saw palmetto extract in an escalating manner at six-month intervals or to an identical-appearing placebo.

The researchers found that there were no significant between-group differences in the rates of serious or non-, changes in vital signs, findings on digital prostate examination, or rates of study withdrawal. There were also no significant differences in laboratory test abnormalities between the groups. Differences in individual laboratory tests were small in magnitude and occurred rarely. There was no evidence of a dose-response effect of saw palmetto.

"Our data suggest that saw palmetto is unlikely to be associated with important, common toxicity for up to 18 months," write the authors. "While the most recent clinical evidence does not support the superiority of saw palmetto over placebo, it appears that men who elect to try the supplement are unlikely to have substantial adverse medical consequences from short-term use."

Placebo and saw palmetto extract were provided by Rottapharm/Madaus. One author disclosed to the Informed Medical Decisions Foundation.

More information: Abstract
Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

High doses of saw palmetto don't impact serum PSA

Feb 08, 2013

(HealthDay)—Compared with placebo, saw palmetto, even at a dose as high as 960 mg, does not affect serum prostate-specific antigen (PSA) levels in men with lower urinary tract symptoms, according to research ...

Latrepirdine not effective in Huntington's disease

Nov 01, 2012

(HealthDay)—Although safe and well tolerated, the experimental small molecule latrepirdine does not improve cognition after six months of treatment in patients with mild-to-moderate Huntington's disease ...

Belimumab deemed safe for long-term lupus treatment

Jun 19, 2012

(HealthDay) -- For patients with systemic lupus erythematosus (SLE), long-term belimumab therapy combined with standard therapy is well tolerated, according to a study published online June 5 in Arthritis & ...

Recommended for you

Researchers ferret out a flu clue

6 hours ago

Research that provides a new understanding as to why ferrets are similar to humans is set to have major implications for the development of novel drugs and treatment strategies.

In the battle against Ebola, a double-layer solution

9 hours ago

When working with Ebola patients, protective gear works, but removing it can be harrowing. Seeking to protect health care workers from the precarious nature of taking off soiled gloves, Cornell students have ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.